ClinicalTrials.gg
RecruitingNCT07205614Updated Apr 28, 2026

The Good Pain Consultation in Endometriosis.

An interventional study of pain consultation, biopsychosocial pain education + usual care and Usual Care in Pelvic Pain Syndrome, Endometriosis and Dysmenorrhea, sponsored by Sorlandet Hospital HF. Recruiting at 1 site in Norway. Open to female participants aged 16 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by Sorlandet Hospital HF · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
16 Years to 50 Years
Sex
Female
01

Study summary

This PhD project investigates the effect of "the good pain consultation" and early integration of biopsychosocial pain education with current standard management of endometriosis. Our goal is to facilitate self-management of pain and improve health-related quality of life (HRQOL) using limited resources.

Our research question is: Does a good pain consultation improve pain self-efficacy and HRQOL, compared to usual care at 3 months and 1 year.?

Researchers will compare a good pain consultation to a control group that will receive usual care.

Participants will:

Attend a consultation and biopsychososial pain education plus usual care or usual care alone.

They will answer questions in an internet-based questionnaires three times point during the study.

02

Conditions studied

  • Pelvic Pain Syndrome
  • Endometriosis
  • Dysmenorrhea
  • Adenomyosis
  • Period Pain
  • Menstrual Pain

Keywords

  • pain education
  • biopsychosocial
  • randomised controlled trial
03

In context

Endometriosis

920 studies on the registry are indexed under Endometriosis; 266 are open to participants now.

This study's planned enrollment of 110 is above the median of 67 across 540 interventional studies indexed under Endometriosis.

Browse Endometriosis studies →

Lead sponsor

Sorlandet Hospital HF is the lead sponsor of 74 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • biological women

Exclusion criteria

Exclusion Criteria:

  • not speaking norwegian
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
110 participants (estimated)

Study arms

  • Experimental
    intervention group

    pain consultation, biopsychosocial pain education + usual care

    Other: pain consultation, biopsychosocial pain education + usual care

  • Other
    control group

    usual care

    Other: Usual Care

Interventions

  • Otherpain consultation, biopsychosocial pain education + usual care

    Participants will receive a link to a digital pain education program. The program will include standard information about endometriosis, but will also introduce a biopsychosocial understanding of pain including influence of psychological factors such as excessive worry, stress, sleep disturbance and emotional distress. Self-management strategies including physical activity, relaxation and breathing techniques, cognitive techniques, psychosocial support and appropriate use of pain medication and supplemental treatment (e.g. physical therapy, TENS, heat), will be introduced. Participants will then attend a single "good pain consultation", a patient-centered consultation with a clinician associated with the project, in which content from the educational package will be reinforced. The consultation will provide the opportunity to address the biopsychosocial factors including anxiety, previous trauma, emotional distress etc. Shared decision-making regarding preferred self-management strat

  • OtherUsual Care

    Usual follow up at the department of gynecology

06

What researchers measure

Primary outcomes

  1. The Pain Self-Efficacy Questionaire

    The Pain Self-Efficacy Questionnaire (PSEQ) is a 10 item self-report questionnaire which assesses confidence people with ongoing pain have in performing activities despite pain. Self-efficacy regarding household chores, socializing, work and coping without medication are assessed. Each item is scored on a 6-point scale, for a total raw score of 0-10 where high scores indicate greater levels of confidence in dealing with pain. The PSEQ is translated to Norwegian and used in previous Norwegian studies.

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

Secondary outcomes

  1. The Short Form-12/Rand 12 Health Survey

    SF-12 is a tool for assessing HRQOL, encompassing eight health domains: physical functioning, role limitations due to physical and emotional problems, bodily pain, general health, vitality, social functioning, and mental health. These domains form two summary measures: the Physical Component Summary (PCS) and the Mental Component Summary (MCS).

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

  2. A single question about Quality of Life

    They will be asked: "All in all, how satisfied are you with your life right now?" we are using a scale from 0 to 10, where 0 means not at all satisfied and 10 means very satisfied.

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

  3. Pain catastrophizing scale (PCS)

    PCS measures pain catastrophizing and "exaggerated negative orientation toward pain stimuli and pain experience". The scale consists of 13 items and includes subscale scores for rumination, magnification and helplessness.

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

  4. The Hopkins Symptom Checklist (HSCL-10).

    The Hopkins Symptom Checklist (HSCL-10) is assessing emotional distress. The HSCL-10 consists of 10 questions assessing symptoms of anxiety and depression (range 1 to 4, most symptoms). Scores ≥1.75 are indicative of increased emotional distress.

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

  5. Numeric rating scales (NRS)

    Numeric rating scales (NRS) rating from 0 to 10 measuring pain intensity. 0 means no pain and 10 means worst possible pain. Three NRS measures will be done registering worst pain intensity and bothersomeness of pain, during the past month

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

  6. The Decreased Sexual Desire Screener (DSDS)

    (DSDS) is a simple, validated diagnostic tool to help to identify and discuss hypoactive sexual dysfunction among women.

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

  7. The Brief Illness Perception Questionnaire (Brief IPQ)

    Brief IPQ is used to assess the cognitive and emotional perception of their illness and consists of nine questions. Answers are scored on a Likert scale from 0-10 scale in the first eight question and the latter question has an open-ended respons. Higher scores indicate more threatening/negative views of their pelvic pain.

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

  8. 2016 Fibromyalgia diagnostic criteria

    The 2016 Fibromyalgia diagnostic criteria are used to identify fibromyalgia based on symptom severity and pain distribution. The criteria include two main components: * Widespread Pain Index (WPI), which Assess pain in 19 body regions over the past week with a Score range: 0-19 (1 point per painful area) * Symptom Severity Scale (SSS) measures severity (0-3) of fatigue, unrefreshing sleep, and cognitive symptoms with a score range: 0-12 Diagnosis is met if: WPI ≥ 7 and SSS ≥ 5, or WPI 4-6 and SSS ≥ 9 and symptoms have been present at a similar level for at least 3 months, with generalized pain in at least 4 of 5 body regions

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

  9. Other questions

    We will ask questions about sociodemographic factors, symptoms related to the condition, and how one lives with the condition. Additionally, medical record information regarding the current condition and comorbidity

    Time frame: The participants will report the outcome measures at baseline and after 12 months.

  10. intention to reconsult and use of healthcare services

    Intention to re-consult, use of health care services and use of medication will be elicited. The partisipant will report this in questionaires, and data will also be collected from national registers.

    Time frame: The participants will report the outcome measures at baseline and after 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07205614
Lead sponsor
Sorlandet Hospital HF
Responsible party
Sponsor
First posted
Oct 3, 2025
Start date
Nov 1, 2025
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2028 (estimated)
Last update
Apr 28, 2026

Study contacts

Inger Johanne W Hansen, MD
Contact
inger.johanne.hansen@sshf.no
+47 38149424
Alexandra Christine Hott, MD, PhD
Contact
alexandra.hott@sshf.no
+47 38149348

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion